Invention Grant
- Patent Title: Thrombin cleavable factor X analogues
- Patent Title (中): 凝血酶裂解因子X类似物
-
Application No.: US10518390Application Date: 2003-06-30
-
Publication No.: US08168753B2Publication Date: 2012-05-01
- Inventor: Virginie Louvain , Elsa Bianchini , Pierre-Emmanuel Marque , Claire Calmel-Tareau , Martine Aiach , Bernard Le Bonniec
- Applicant: Virginie Louvain , Elsa Bianchini , Pierre-Emmanuel Marque , Claire Calmel-Tareau , Martine Aiach , Bernard Le Bonniec
- Applicant Address: FR Paris
- Assignee: Institut National de la Sante et de la Recherche Medicale
- Current Assignee: Institut National de la Sante et de la Recherche Medicale
- Current Assignee Address: FR Paris
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: FR0208299 20020703
- International Application: PCT/EP03/07793 WO 20030630
- International Announcement: WO2004/005347 WO 20040115
- Main IPC: A61P7/00
- IPC: A61P7/00 ; A61K38/36 ; C12N15/00 ; C12N5/00 ; C07K14/745
Abstract:
The invention relates to factor X analogues containing the thrombin-cleavable sequence Pro-Arg-Ala in place of the-sequence Thr-Arg-Ile of the activation site of native factor X. These factor X analogues can be used to obtain procoagulant medicinal products.
Public/Granted literature
- US20060148038A1 Thrombin cleavable factor x analogues Public/Granted day:2006-07-06
Information query
